Healthcare Global Enterprises IPO GMP History
Healthcare Global Enterprises IPO has been listed on March 30, 2016 at a listing price of ₹210.2, against the issue price of ₹218 — a loss of ₹7.8 (-3.58%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Healthcare Global Enterprises IPO raised ₹649.64 Cr. through its IPO at a price band of ₹205 to ₹218 per share, with a lot size of 65 shares. The IPO was open for subscription from 16 Mar 2016 to 18 Mar 2016.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:10 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Healthcare Global Enterprises IPO dates
Key dates from opening to listing. Today is 13 November.
- Open 16 Mar 2016
- Close 18 Mar 2016
- Allotment 23 Mar 2016
- Refund/credit TBA
- Listing 30 Mar 2016
Healthcare Global Enterprises IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹218 |
|---|---|
| Listing gain / loss | −₹7.8 per share |
| Listing date | 30 Mar, 2016 |
| Actual listing price | ₹210.2 (-3.58%) |
Is Healthcare Global Enterprises IPO GMP reliable?
Grey market premium for Healthcare Global Enterprises IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Healthcare Global Enterprises IPO full review for a fundamentals-based assessment before making any grey market trades.
Healthcare Global Enterprises IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Healthcare Global Enterprises IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Healthcare Global Enterprises IPO
Healthcare Global Enterprises Limited is a Bangalore based speciality healthcare provider focused on cancer and fertility. Its promoters include BS Ajai Kumar.
It runs the largest cancer care network in India by number of licensed private cancer treatment centres.
As of 31 December 2015 its network had 14 comprehensive cancer centres, and it runs fertility centres under the Milann brand.
The IPO was Rs 649.64 crore, with Rs 252.88 crore of fresh issue and Rs 396.76 crore of offer for sale, at Rs 218, the top of the Rs 205 to Rs 218 band. The fresh money was for medical equipment, IT and prepaying debt.
Frequently asked
What is the GMP of Healthcare Global Enterprises IPO?
The current Grey Market Premium (GMP) of Healthcare Global Enterprises IPO is not yet started or active in the market.
What is the Kostak Price of Healthcare Global Enterprises IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Healthcare Global Enterprises IPO is not available.
What is the Subject to Sauda Price of Healthcare Global Enterprises IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Healthcare Global Enterprises IPO?
Healthcare Global Enterprises IPO listed on March 30, 2016 at ₹210.2, against the issue price of ₹218 — a loss of -3.58%.
How did the GMP of Healthcare Global Enterprises IPO trend before listing?
The GMP of Healthcare Global Enterprises IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Healthcare Global Enterprises IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
